Stay updated on ALXN1210 vs Eculizumab in PNH Clinical Trial
Sign up to get notified when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.

Latest updates to the ALXN1210 vs Eculizumab in PNH Clinical Trial page
- Check3 days agoChange DetectedThe page’s UI/release revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without changing the study record content.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Naples, Italy (80131) to the study locations and updated the page revision to v3.5.0; Napoli, Italy (80131) was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No changes to study data or essential content are apparent on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed. This appears to be a minor administrative update with no changes to study design or participant information.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ALXN1210 vs Eculizumab in PNH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALXN1210 vs Eculizumab in PNH Clinical Trial page.